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 SUMMARY 
Introduction. Coronary artery disease with an eventual coronary occlusion and subsequent 
myocardial injury is one of the leading causes of death in the world. Besides spontaneous 
reperfusion of an occluded artery thrombolysis and percutaneous transluminal coronary 
angioplasty (PTCA)are two procedures performed widely, that aim for the restoration of 
blood flow, i.e. also result in reperfusion. Reperfusion may increase injury over and above 
that sustained during ischemia. One of the suggested mechanisms of so-called reperfusion 
injury is the generation and action of reactive oxygen species (ROS). Although in clinical 
conditions timely reperfusion of the ischemic area is the cornerstone of treatment, there is a 
possible role of antioxidant therapy to limit ischemia-reperfusion injury.  
Aims. I. To investigate the protective efficacy of H290/51, a low molecular weight, 
hydrophilic compound with effects similar to Vitamin E and inhibiting lipid peroxidation, on 
hypoxia-reoxygenation injury of isolated cardiomyocytes. 
II. To study the effect of H290/51 on oxidative injury induced by exogenous ROS in isolated, 
perfused rat hearts. 
III. To examine its effect on ultrastructural changes in isolated rat hearts subjected to ischemia 
and reperfusion. 
IV. To assess the effect of inhibiting lipid peroxidation on functional and biochemical injury 
caused by global, normothermic ischemia-reperfusion in isolated rat hearts. 
Methods. I. Neonatal myocytes were cultured. On day 6 cells were rendered hypoxic for 1 
hour followed by 4 hours of reoxygenation. Lactate dehydrogenase (LDH) leakage was 
assessed.  
II. Oxidative injury was induced in isolated rat hearts by perfusion with H2O2 for 10 min, 
followed by 50 minutes of recovery. Functional (heart rate [HR], coronary flow [CF], left 
ventricular end-diastolic pressure [LVEDP], left ventricular developed pressure [LVDP]) and 
biochemical ([LDH leakage], thiobarbituric acid parameters were measured. 
III. Isolated rat hearts were subjected to 30 minutes of global, normothermic ischemia, 
followed by 20 minutes of reperfusion. Hearts were sampled for electron microscopy. 
Quantitative stereological morphometry was employed. 
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IV. Isolated rat hearts were subjected to 30 minutes of global, normothermic ischemia, 
followed by reperfusion for 20 minutes. Functional (HR, CF, LVDP, LVEDP) and 
biochemical (LDH leakage, TBARS) parameters were measured. 
Materials. A novel low molecular weight indenoindole derivative, H290/51 (cis-5, 5a, 
6,10,b-tetrahydro-9-methoxy-7-methylindeno [2,1-b]indole) was selected as the antioxidant in 
the experiments. The compound is an inhibitor of lipid peroxidation, with balanced hydro- 
and lipophilicity, thus it can rapidly penetrate cell membranes to intracellular sites of ROS 
generation, lipid peroxidation and oxidant injury.  
Results. I. H290/51 inhibited LDH leakage in isolated cardiomyocytes induced by hypoxia-
reoxygenation in a dose-dependent manner. 
II. H290/51 attenuated diastolic dysfunction as it inhibited the increase in LVEDP caused by 
H2O2. The protective effect was further evidenced by the inhibition of both LDH release and 
accumulation of TBARS after H2O2 exposure. 
III. Ischemia-induced increase in interstitial volume and in volume fractions of myocytes and 
interstitium was inhibited by H290/51. The difference was already present at the end of 
ischemia, but disappeared during reperfusion. 
IV. Ischemia caused an increase in LVEDP and decrease in LVDP and CF, and induced 
malignant arrhythmias. H290/51 effectively inhibited these changes if it was administered 
throughout the experiment including the stabilization period before ischemia, but was less 
potent when given only during reperfusion.  
Conclusion. Our study indicates that inhibiting lipid peroxidation by H290/51 counteracts 
several deleterious processes in an experimental myocardial ischemia/reperfusion injury 
model. Our data indicate that to some extent its antioxidant properties may be effective not 
only during reperfusion, but already during ischemia. Thus, a better preserved functional and 
morphological status of the myocardium during ischemia may yield a better capacity to 
survive reperfusion injury. The chemical properties of the compound, most importantly its 
balanced hydro- and lipophilicity and its small molecular weight result in its ability to rapidly 
reach the intracellular sites where induced free radicals are produced. Clinically, such 
properties might be of therapeutic value, and H290/51 may therefore be a promising candidate 
for clinical evaluation and further study. 
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INTRODUCTION 
Coronary artery disease, in particular in the form of acute myocardial ischemic syndromes, 
remains the principle cause of mortality, morbidity and early disability in the industrialised 
world. These events are usually triggered by a coronary artery occlusion at the site of a 
ruptured plaque that leads to myocardial ischemia and subsequent severe tissue injury and cell 
death in a time-dependent manner. The major goal of treatment is to restore blood flow to the 
jeopardised myocardial area. New techniques, such as percutaneous transluminal coronary 
angioplasty (PTCA) and thrombolysis in the acute phase of an impending myocardial 
infarction rapidly gained wide acceptance as the appropriate therapy for re-establishing 
perfusion to ischemic areas of the myocardium. A common example of global reperfusion in 
clinical practice is open-heart surgery with cardioplegia (Vaage and Valen, 1993).  
Reperfusion injury and its clinical relevance  
Although an absolute pre-requisite for tissue survival, it is widely accepted that reperfusion 
may increase injury over and above that sustained during ischemia (Hearse, 1998; Ambrosio 
and Tritto, 1999). Thus, there exists a paradox in that tissue viability can be maintained only 
if reperfusion is installed as soon as possible, but only at the risk of extending the injury 
beyond that already having occurred during ischemia. As injurious components may partly 
counteract the otherwise beneficial effects of reperfusion, this phenomenon has thus been 
termed “reperfusion injury” (Braunwald and Kloner, 1985; Becker and Ambrosio, 1987). This 
phenomenon may have major clinical implications in such frequent and important clinical 
conditions as angina or in procedures performed to recover vascular patency like 
thrombolysis, angioplasty and cardiac surgery, where ischemia is followed by reperfusion. 
The consequences of ischemia-reperfusion injury include a series of events: (a) reperfusion 
arrhythmias, (b) myocardial stunning, a reversible impairment of contraction, (c) 
microvascular damage and no-reflow, and probably (d) lethal reperfusion injury where 
irreversible injury with cell death occurs (Dhalla et al., 2000; Ferrari and Hearse, 1997). 
These phenomena have been described in humans and may partly be reproduced in various 
animal models (Hearse, 1990). 
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Pathophysiology of reperfusion injury, oxygen free radicals 
Ischemia-reperfusion injury can be explained by two hypotheses: the oxygen paradox and 
Ca2+-overload. During reperfusion, sequential reduction of molecular oxygen occurs ending in 
formation of reactive oxygen substances (ROS). This forms the basis of the oxygen paradox, 
on the premise that while oxygen is essential for tissue survival, it can be injurious during 
reperfusion of ischemic myocardium (Park and Lucchesi, 1999). Oxidative stress damages the 
sarcolemmal Ca2+ pump regulatory mechanisms which results in intracellular Ca2+ overload 
(Kaplan et al., 1997). These mechanisms are most likely related to each other. Substantial 
evidence indicates that ROS are important mediators of myocardial ischemia-reperfusion 
injury (Bolli, 1990). ROS are chemical species with one or more unpaired electrons in their 
outer orbit, which highly increases their reactivity and makes them capable of inducing 
oxidative modification of other molecules (Blake et al., 1987) The addition of a single 
electron to molecular oxygen results in the production of superoxide anion radical (O2-). 
Formation of superoxide anion is the first of several steps in forming other oxygen-derived 
reactive products, which include hydrogen peroxide (H2O2) and hydroxyl radical. H2O2 is not 
a radical by itself, but is capable of causing cell damage by interacting with transition metals 
such as iron. A single electron reduction of H2O2 results in the formation of the hydroxyl 
radical, which is highly reactive and has a very short half-life. Peroxynitrite (ONOO-) is 
another possible contributor to reperfusion injury. The first excited state of O2 is a singlet 
oxygen (1O2) that is non-radical in itself, but can also initiate radical chain reactions. 
 
In the heart ROS can be produced in the sarcoplasmic reticulum, the mitochondria, the 
vascular endothelium and by aggregating neutrophils (Nayler, 1992; Thompson and Hess, 
1986). It should be noted that a number of sites, at which ROS may be produced, are 
intracellularily located, thus not easily available to exogenous antioxidant compounds. There 
are different sources of ROS during ischemia-reperfusion. Oxygen is essential for ATP 
production in the mitochondria. Under normal conditions some ROS are formed during 
mitochondrial electron transport, and these are inactivated by intracellular antioxidant 
systems. During hypoxia and ischemia, however, the mitochondrial electron transport chain in 
the myocyte is disrupted and a massive accumulation of ROS occurs. Other sources of ROS 
are endothelial cells and activated leukocytes. Most likely H2O2 is the ROS species that is 
produced by activated leukocytes during ischemia-reperfusion (Kraemer et al., 1990). ROS, 
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through the formation of lipid peroxides and hydrogen peroxide, inhibit membrane bound 
enzymes and initiate chain-propagation reactions, which cause diminishing membrane fluidity 
and increasing membrane permeability. Intracellularily, the sarcolemma and mitochondrial 
membrane structures are most prone to ROS-induced damages (Hess et al., 1983). Membrane 
abnormalities may cause a serious defect in calcium regulation and cellular volume, inducing 
mitochondrial dysfunction, calcium overload and cellular swelling. These injuries can 
eventually lead to cell death (Steenbergen and Jennings, 1991, Ambrosio et al., 1991). ROS 
can also damage nucleic acids causing mutations and cell death (Singal et al., 1999). ROS 
also increase leukocyte activation, chemotaxis, and leukocyte-endothelial adherence after 
ischemia-reperfusion (Collard and Gelman, 2001). 
Role of ROS 
The role of ROS in the pathogenesis of myocardial reperfusion injury is substantiated 
experimentally by a) the detection of ROS in the reperfused myocardium; b) exposure of 
myocardium to exogenous ROS yields biochemical and functional dysfunction similar to that 
caused by ischemia-reperfusion; and c) treatment with antioxidants affords protection against 
reperfusion injury. 
 
Production of ROS can be measured directly and indirectly (Saran and Bors, 1991). 
Production of ROS was detected in small amounts in vivo in the intact beating heart (Grill et 
al., 1992). ROS production increases during ischemia at least three-fold, and subsequently 
there is an additional burst in production during reperfusion which has been measured in vivo 
by electron paramagnetic resonance spectroscopy (Zweier et al., 1987). Severe ischemia 
induces a reduction in the tissue concentration of various scavenger compounds that protect 
against oxygen toxicity (Ferrari et al., 1985). Lipid peroxidation is detected through the 
estimation of malondialdehyde (MDA) either by chemiluminescence, HPLC or the 
thiobarbituric acid (TBARS) method. MDA is an end-product of oxidative lipid degradation, 
itself biologically active. TBARS are usually regarded as an indicator of MDA production, 
despite their limitations due to lack of specificity (Esterbauer et al., 1991). Biological end-
points of ROS can be determined as functional, metabolic and morphologic parameters. The 
generation of ROS was found in humans also by coronary sinus sampling during primary 
PTCA for myocardial infarction (Grech et al., 1995). Experimentally, estimation of the role of 
[NA1] megjegyzést írt: ref 
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ROS is possible by pharmacological addition of scavengers or antioxidants, or manipulation 
with endogenous protection. Usually a combination of indirect measurements is employed to 
study the effects of ROS. 
Endogenous defence against ROS 
Under physiological conditions the tissue concentration of free radicals is maintained by a 
system of enzymatic and non-enzymatic antioxidants. It is estimated that approximately 5% 
of the oxygen consumed by normal tissues is transformed into ROS (Lefer and Granger, 
2000). Superoxide dismutase (SOD) enzymatically protects against O2- (Thompson and Hess, 
1986). H2O2 is enzymatically scavenged by gluthathione peroxidase or catalase (Thompson, 
1986). Ischemia causes a decrease in mitochondrial glutathione peroxidase activity, thus 
detoxification of H2O2 is impaired (Shlafer et al., 1987). SOD and catalase have recently been 
found to be protective in myocardial ischemia-reperfusion injury in a genetically engineered 
animal model (Chen et al., 1998). There is no physiological scavenger against OH, and the 
defence is directed against preventing its formation. The enzymatic defence predominates 
within the cell. Extracellular defence is mainly exerted through metal binding proteins such as 
transferrin and ceruloplasmin (Thompson, 1986). 
 
Among the non-enzymatic antioxidants, -tocopherol (Vitamin E) is the most efficient in the 
lipid phase. It is a fat-soluble antioxidant, which is mainly present in the plasma, low-density 
lipoprotein particles and the cell membrane (Burton et al. 1982). In comparison with striated 
muscular tissue the myocardium has a high concentration of Vitamin E (Kornbrust and Mavis, 
1979). It has recently been shown that plasma Vitamin E levels correlate well with coronary 
endothelial function (Kinlay et al., 1999). Other important endogenous antioxidants are 
Vitamin C (Packer et al., 1979) and ubiquinone (Forsmark et al., 1991).  
Lipid peroxidation 
Lipid peroxidation has been suggested to be a main mechanism of oxidative injury (Noronha-
Dutra and Steen, 1982; Ceconi et al., 1992; Parinandi et al., 1991). The removal of a hydrogen 
atom from the unsaturated site in a fatty acid results in the production of a lipid radical. The 
addition of ROS to lipid radicals results in the formation of lipid peroxides (Singal 1999). 
Lipid peroxidation is accompanied by an altered distribution of membrane-located receptors 
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(Davies, 1987), denaturation of proteins and inactivation of enzymes (Kramer et al., 1986), 
alterations of cellular membrane lipoproteins causing functional disturbances (Manciet and 
Copeland, 1992) and ultimately the destruction of membranes and cell necrosis (Bolli, 1991; 
Southorn and Powis, 1988). Inhibition of lipid peroxidation has been shown to be protective 
against reperfusion-induced myocardial damage (Janero and Burghardt, 1989; Ferrari et al., 
1991). Lipid peroxidation is characterised by three phases: initiation, propagation and chain 
termination (Esterbauer, 1991). Chain-breaking antioxidants can suppress free radical chain 
oxidation during the oxidation of lipids. In vivo, ascorbic acid is an outstanding antioxidant in 
the plasma. However, it may not be an ideal antioxidant against lipid peroxidation of 
lipoproteins and membranes due to its hydrophilicity. The most important lipid-soluble chain-
breaking antioxidant in biological membranes in vivo is Vitamin E, and it has been tested and 
proven effective in protecting from oxidative stress (Halliwell, 1990). Vitamin E-treated rats 
showed a decrease in mortality and infarct size due to coronary occlusion by approximately 
50% compared to the control group (Sethi et al., 2000). In another study, however, Vitamin E 
was not effective in reducing infarct size after ligation of a coronary artery (Bellows et al., 
1995). The disadvantage of Vitamin E is that its extreme lipophilicity causes a slow 
availability to cardiomyocytes. This can explain why treatment with Vitamin E just prior to 
the ischemia-reperfusion episode is of limited value only, and why effective pretreatment 
needs large doses employed (Axford-Gately et al., 1993). These pharmacokinetic 
characteristics of Vitamin E render it less feasible in acute ischemic situations; hence other 
drugs should be investigated with similarity in action to Vitamin E but with a more favourable 
pharmacokinetic profile. 
Therapeutical possibilities 
It is important to establish optimal conditions for reperfusion so as to preserve as much of the 
myocardium as possible, particularly in view of the fact that the prognosis following 
myocardial infarction is highly influenced by the remaining left ventricular function. As a 
growing body of evidence exists that oxidative processes play a role in cardiac diseases, it 
seems reasonable to include antioxidants among therapeutic strategies. Some of the most 
prominent pharmaceuticals currently employed in cardiovascular medicine, like captopril or 
carvedilol are already known to have antioxidant properties as well (Wattanapitayakul and 
Bauer, 2001).  
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A number of antioxidants have been tested for their possible protective effect in ischemia-
reperfusion injury of the heart (Opie, 1989, Manson et al., 1993). The results are far from 
consistent, ranging from a marked protection to no protective effects at all (Uraizee, 1987, 
Klein et al., 1991). Experimentally, SOD and catalase have gained the most attention as of 
possible value in the treatment of reperfusion injury. These antioxidant enzymes have been 
found to be cardioprotective in a number of experimentally induced ischemia-reperfusion 
models (Jolly et al., 1984; Mehta et al., 1989). Unfortunately, SOD treatment was reported to 
be ineffective in many other publications. Moreover, recombinant SOD (h-SOD) provided no 
additional protection in a large, multicenter clinical trial in patients undergoing angioplasty 
(Flaherty, 1994; Uraizee et al., 1987). Consequently, it has been suggested that antioxidant 
strategies should involve low molecular weight compounds that are capable of both 
scavenging ROS and gaining access to the intracellular compartments where ROS are 
produced and where a major part of the deleterious action of ROS is effected (Lesnefsky, 
1992; Maxwell and Lip, 1997).  
H290/51 
A novel indenoindole derivative, H290/51 (cis-5, 5a, 6,10,b-tetrahydro-9-methoxy-7-
methylindeno [2,1-b] indole), a low molecular weight (288 MW) inhibitor of lipid 
peroxidation, is an effective quencher of radical chain propagation rather than an inhibitor of 
free radical production. Similarly to Vitamin E, it has the ability to recycle with ascorbate 
(Björquist et al., 1996). The lipophilicity of H290/51 is considerably lower than that of 
vitamin E. The log P value (-log[compound soluble in octanol]/[compound soluble in water] 
is 3.5 for H290/51. Consequently, H290/51 is much more hydrophilic than vitamin E (log P > 
12), but more lipophilic than Vitamin C (log P < 2.9). The inhibitory potency, IC50: -
log[compound] to reduce TBARS formation by 50% in Fe/ascorbate-induced production in 
phospholipid vesicles, is 8.2 for H290/51 compared with 5.6 for Vitamin E (Westerlund et al., 
1996). This drug is of particular interest, since its small molecular weight and balanced hydro- 
and lipophilicity make it suitable for rapid cellular uptake. It can rapidly penetrate cell 
membranes to intracellular sites of ROS generation, lipid peroxidation, and oxidant injury. 
Theoretically H290/51 may effectively give protection to jeopardised subcellular 
compartments and protect the myocardium fromischemia- reperfusion injury. 
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AIMS OF THE STUDY 
The main objective of the present investigation was to study the effects of inhibiting lipid 
peroxidation by a novel, low molecular weight antioxidant in different models of ischemia-
reperfusion. 
The individual studies were conducted with particular emphasis on the following objectives: 
 
I. To investigate the protective efficacy of H290/51, a hydrophilic compound with similar 
effects to Vitamin E on hypoxia-reoxygenation injury of isolated cardiomyocytes. 
II. To study its effect on oxidative injury induced by exogenous ROS in isolated, perfused rat 
hearts. 
III. To examine its effect on ultrastructural changes in isolated rat hearts subjected to ischemia 
and reperfusion. 
IV. To assess the effect of inhibiting lipid peroxidation on functional and biochemical injuries 
caused by global, normothermic ischemia-reperfusion in isolated rat hearts 
O 
N 
H 
Fig. 1 
Chemical structure of indenoindole 
derivative H29/51 
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METHODS  
Animals 
The experiments were approved by the Regional Ethics Committee at the Karolinska Institute, 
Stockholm, Sweden. All animals received care in compliance with the Guide for the Care and 
Use of Laboratory Animals published by the National Institutes of Health. . 
Experimental set-up 
Cultured cardiomyocytes  
Neonatal hearts were collected from rats between 2 and 6 days of age. The ventricles were 
dissected free, placed in Hanks balanced salt solution without Ca2+ and Mg2+, but with 0.35 
g/l sodium carbonate, and cut in small pieces. The cells were dispersed in the same solution, 
but supplemented with collagenase solution (type 1, 0.8 mg/ml) at 37 C for 10 min, and 
centrifuged at 160 g for 5 min. Subsequently, five serial 20 minutes digestions were 
performed, and the cells from the initial digestion were discarded. After each digestion period 
the cells were collected by centrifugation and suspended in Ham's F10 culture medium, 
supplemented with 10% fetal bovine serum, glutamine 2 mmol/l, penicillin 50 IU/ml, and 
streptomycin 50 g/ml. To enrich the isolation of myocytes, the cells were replated twice for 
30 and 90 min. The myocytes were plated on 35 mm plastic culture dishes at a density of 
approximately 9  105 cells/ml (1.8  106 cells/dish). The cells were kept in culture for 6 days 
at 37 oC and 5 CO2 under aerobic conditions in a carbon dioxide incubator (Forma 
Scientific). During this period the cells were beating spontaneously at a frequency of 20-40 
beats/min. Each culture dish contained 0.9  0.2 mg protein (n = 9). The supplemented F10 
medium was changed each day. Before starting the experiments, the medium was removed 
and changed to 4 ml F10 medium without antioxidant and serum, but supplemented with 
glutamine. To obtain hypoxic conditions, the medium was saturated by bubbling argon. The 
culture plates were transferred to specially designed, air tight, thermostat-controlled chambers 
with the ability to withdraw samples from each culture dish (Ek, 1994). The experiment lasted 
for 5 h, including 1 h hypoxia, when a mixture of 95% N2 and 5% CO2 was slowly gassed 
above the cells, followed by 4 h reoxygenation (95% O2 and 5 % CO2). The hypoxic 
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procedure reduced oxygen from 20 to 5% after 3 min, and to 1.2% after 10 min. 
Reoxygenation increased oxygen to 24% after 5 min, and was 80% within 30 min. Cell 
damage was assessed by leakage of lactate dehydrogenase (LDH) to the medium, and was 
analysed in aliquots of 100 l after 1, 2, 3, 4, and 5 h. 
Isolated rat heart 
Male Sprague-Dawley rats, weighing 250-300 g, anesthetised with diethyl ether were used. 
Heparin (200 IU) was injected into the femoral vein. The hearts were rapidly excised through 
a median sternotomy and immediately immersed into ice-cold Krebs-Henseleit buffer during 
preparation. The ascending aorta was cannulated for retrograde perfusion as a modified 
Langendorff preparation (Langendorff 1895). Perfusion pressure (100 cm H2O) and 
temperature (37 oC) were kept constant.  
 
In experiments II and IV left ventricular systolic (LVSP) and end-diastolic pressures 
(LVEDP) were measured isovolumetrically via a fluid filled latex balloon introduced into the 
left ventricle through the left atrium. Left ventricular developed pressure (LVDP) was 
calculated (LVSP-LVEDP). Heart rate (HR) was counted from the pressure curves. Coronary 
flow (CF) was measured by timed collections of the coronary effluent. 
 
The hearts were perfused with Krebs-Henseleit buffer containing glucose (NaCl 118.5mM, 
NaHCO3 25.0 mM, KCl 4.7 mM, KH2PO4 1.2 mM, MgSO4 x7H2O 1.2 mM, CaCl2 2.4 mM, 
Glucose x H2O 11.1 mM) and bubbled with a gas mixture containing 95% O2 and 5% CO2. 
Coronary flow (CF) was measured by collecting the coronary effluent every 2.5 min to adjust 
drug infusion to changes in flow (see page 19, “Chemicals”). The perfusion protocol started 
with a 25 minutes stabilisation period. Only hearts that met the following criteria at the end of 
stabilisation were included: CF: 7-15 ml/min, HR: 260-360 beats/min, LVSP: 50-150 mmHg 
and LVEDP: 0 mm Hg. In Study III the insertion of the intraventricular balloon was omitted 
and only CF was used to evaluate stability. In experiments III and IV global, normothermic 
ischemia was induced by clamping the inflow tubing for 30 minutes, followed by 20 minutes 
of reperfusion. In study II hydrogen peroxide (H2O2) was added to the perfusate to groups as 
listed below.  
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In Study IV LVEDP, CF, and HR were measured at 0, 2, 5, 10, 15, 20, 30, 40 and 60 min, and 
in Study II at the same time points except 2 and 40 min. At time 0, and after 2, 5, 10, 20 and 
60 minutes of reperfusion aliquots of coronary effluent were collected in precooled tubes, 
rapidly frozen, and stored at –80oC until analysed for LDH activity. (Sampling was not done 
at 2 and 5 min in Study IV).  
 
In Studies II and IV hearts were freeze-clamped with liquid nitrogen at the end of the 
experiments (60 min), and stored at –80 oC before processing and analysis of tissue contents 
of thiobarbituric acid-reactive substances (TBARS). Additional hearts were freeze-clamped 
after 15 and 20 min (n = 8 in each group at each time point for freeze clamping). Results from 
hearts in group 1 obtained at time 0 served as baseline values for all freeze-clamped groups, 
because all hearts were treated equally during stabilisation. Hemodynamic data from the 
freeze-clamped hearts are not included.  
Preparation for Electron Microscopy 
At the end of experiments hearts were perfusion-fixed with McDowel’s fixative for 10 min at 
room temperature and at a perfusion pressure of 60 cm H2O (McDowel and Trump, 1976) . 
Only the ventricular myocardium was used for morphometry. The volume of the ventricular 
myocardium was measured by liquid displacement and expressed in l for further 
calculations. The hearts were then kept in fixative. At the final processing the ventricles were 
cut into 1 and 2 mm thick parallel slices with a razor blade apparatus (Baddeley et al., 1986) . 
All the 1 mm thick slices were then placed at random under a regularly perforated Plexiglas 
plate. The perforations were placed in a square (32mm  32 mm) and separated from each 
other by a distance of 2 mm. Each perforation had a diameter of 1 mm. One biopsy was taken 
at every second perforation using a biopsy needle. Postfixation was performed in 1% aqueous 
OsO4 for 2 hours. After a subsequent wash in buffer the pieces were stained in 2% uranyl 
sulphate for 1.5 h. The pieces were dehydrated in a series of graded alcohol before embedding 
in a mixture of Epon and Araldite. Eight pieces of ventricular biopsies were taken from each 
animal, and out of this, five samples were selected randomly for further stereologic 
processing. Thin sections were stained with Reynolds lead citrate for 8 min, and subsequently 
(2016.07.03.NA PhD FINAL.doc) 18 
with 5% uranyl sulphate for 5 min. A randomised procedure was used to select fields to be 
photographed. A section from each randomly selected biopsy was covered by a grid 
consisting of 10 fields and every second field was photographed totalling 5 fields per sample. 
This procedure ensured randomness at all steps in the process. All micrographs were taken at 
a magnification of 4000. Thus, a total of 25 micrographs per heart were the basis of 
quantitative evaluation. 
Stereology 
Volume fractions were estimated using the point counting method (Weibel, 1973). A counting 
grid with sampling points was laid on the micrographs and points overlying on different tissue 
and cell components were counted and related to points falling on the whole myocardium. 
Volumes of mitochondria, altered mitochondria and cellular edema were estimated as 
fractions of myocyte volume and denoted: Vv (mito/myocyte), Vv (alt mito/myocyte), Vv (cell 
edema/myocyte). Volume fractions of myocytes, interstitium and capillaries in total 
myocardium were estimated: Vv (myocyte /myocard), Vv (interstitium /myocard), Vv (capillary 
/myocard). The absolute volume of different tissue components was calculated by multiplying 
the volume fraction of the tissue component with the respective measured ventricular volume 
and given as l. In addition, the planar sections of cells appearing on micrographs from 
different groups were inspected. A semiquantitative evaluation was undertaken. Rounded 
mitochondria with reduced contrast (loss of matrix density) and more pronounced changes in 
mitochondria were counted as altered mitochondria. Cellular edema was defined as clear 
spaces in the cytosol of the myocytes.  
Experimental groups 
Studies with cultured myocytes (Study I) 
Compound H290/51 was added to the culture medium for the 6 days of culturing at a final 
concentration of 10-8, 10-7, 10-6, and 5  10-6 mol/l in 0.1% ethanol. The medium was 
subjected to 1 hour of hypoxia. LDH leakage was assessed from samples taken after 1, 2, 3 
and 4 hours after reoxygenation. 
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Isolated rat hearts subjected to oxidant stress by hydrogen peroxide (Study II) 
Group I: H2O2 was given for 10 minutes, followed by 50 minutes of recovery (n = 9) 
Group II: Vehicle of H290/51 was given to the buffer for 10 minutes (n = 9) 
Group III: H290/51 was added for 10 minutes (n = 8) 
Group IV: Like group I, and H290/51 was added from time 0 onwards (n = 12) 
Group V: Like group I, and H290/51 was added from 10 minutes onwards only (n = 12) 
Isolated rat hearts subjected to ischemia-reperfusion – quantitative electron microscopical 
morphometry (Study III) 
Group A: control hearts perfused with buffer and vehicle subjected to ischemia and 
reperfusion. Hearts were sampled at the end of stabilisation (time 0), at the end of ischemia 
(30 minutes) and at the end of reperfusion (50 minutes; n=6 at each time point in each group).  
Group B: like Group A, but with H290/51 added throughout both stabilisation and 
reperfusion. Hearts were sampled as in Group A.  
Group C: hearts were not subjected to ischemia, but H290/51 was added throughout the 
experiment. Hearts in this group were only sampled for morphometric evaluation at 50 min. 
Isolated rat hearts subjected to ischemia-reperfusion – biochemical and functional analysis 
(Study IV) 
Group 1: ischemia – reperfusion with buffer only (n = 25) 
Group 2:Like 1, but vehicle added throughout 25 min stabilisation and reperfusion (n = 18)  
Group 3: Like group 2, but H290/51 added throughout reperfusion (n = 21) 
Group 4:Like 1, but H290/51 added throughout both stabilization and reperfusion (n = 13) 
Biochemistry 
LDH activity in the coronary effluent and cell medium was measured in a Cobas Bio 
centrifugal analyser (Hoffmann-La Roche, Switzerland) by using a commercial reagent kit 
(Boehringer-Mannheim, Germany, Cat. No. 191353). LDH in the coronary effluent is 
presented as activity in units (U) released per minute.  
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In the study on isolated myocytes the LDH values were expressed as reoxygenation/hypoxia 
ratios, calculated from the LDH leakage (U/l medium) after different times of reoxygenation 
divided by the LDH leakage after 1 hour of hypoxia. 
 
TBARS. Myocardial samples were homogenised in a glass/glass homogeniser using a 0.1 M 
potassium phosphate buffer at pH 7.4. The tissue weight/volume ratio was ½, and the buffer 
contained 2.5 mg/ml desferoxamine. The formation of TBARS was quantified using an 
automated continuous-flow technique (Svensson et al., 1993).  
Chemicals 
H290/51 (AstraZeneca R & D, Mölndal, Sweden), was dissolved in a vehicle containing 
polyethylene glycol, ethanol and water in a 40:10:50 w/w percentage ratio. H290/51 or 
vehicle alone was administered with an infusion pump at a rate of 1/20th of coronary flow into 
a mixing chamber immediately upstream to the aortic cannula, to obtain a concentration of 
10-6 mol/l in the coronary circulation. In experiment II H2O2 was added directly to the 
perfusate at a concentration of 180 M. 
Statistical methods 
Data in Studies I, II and IV were presented as mean  standard error of the mean (SEM). In 
Study III values were given as mean  standard deviation (SD). The differences between 
groups were calculated by the non-parametric Mann-Whitney test. In Study I p-values were 
corrected according to the Bonferroni method. In Study I for analysis of arrhythmias, data 
were pooled according to groups to raise the number of observations in each category, and the 
chi-square test with Yates correction was used. The pairwise Wilcoxon Signed Rank Test was 
used to analyse differences within groups. In all statistical tests p < 0.05 was considered 
significant.  
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RESULTS  
Hypoxia-reoxygenation injury of isolated cardiomyocytes 
The effect of H290/51 on LDH leakage induced by reoxygenation is presented in Fig. 2. The 
time related increase in LDH leakage was reduced by increasing the concentration of H290/51 
in the medium. At a concentration of 10-6 mol/l, LDH leakage was almost totally inhibited. 
The pIC50 to reduce LDH leakage by 50% was calculated as 7.2  0.4. 
 
Fig. 2. Effect of H290/51 on reoxygenation induced 
LDH leakage in isolated myocytes. LDH-values are 
expressed as reoxygenation/hypoxia ratios, calculated 
from the LDH-leakage expressed in U/L after l, 2, 3 
and 4 hours reoxygenation divided by the LDH-
leakage after 1 hour hypoxia. Control (-), 
0.01( - ), 0.1(- ), 1.0 ( - ) and 5.0 (-) 
M H290/5l. Mean values ± SEM, n=3. 
 
 
Isolated rat hearts subjected to oxidant stress by hydrogen peroxide 
Functional measurements 
Left ventricular end-diastolic pressure 
LVEDP remained at baseline level (0 mmHg) throughout perfusion in hearts given either 
H290/51 (group III) or vehicle alone (group II) (Fig. 3). LVEDP increased significantly 
already after 5 minutes of H2O2 administration (group I) to 6±1 mmHg and remained elevated 
throughout the experiment with a maximum of 32±7 mmHg at 20 min. Administration of 
H290/51 (group IV) attenuated the increase in LVEDP. At 15 min LVEDP was 16±3 mmHg 
in group V and then gradually decreased, being less than in group I at 20 min (9±3 mmHg, p<
0.006), 30 min (3±1 mmHg, p<0.001) and 60 min (2±1 mmHg, p<0.002)(Fig. 3). At 30 and 
min
0 60 120 180 240 300
L
D
H
 l
e
a
k
a
g
e
 (
U
/L
) 
fr
o
m
 i
s
o
la
te
d
 m
y
o
c
y
te
s
2
4
6
8
Megváltozott a mezőkód
Megváltozott a mezőkód
(2016.07.03.NA PhD FINAL.doc) 22 
60 min LVEDP in group IV was not different from controls (group III). Addition of H290/51 
to perfusate after the end of H2O2 perfusion (group V) resulted in an intermediate course as 
compared to group I and group IV (Fig. 3), without being significantly different, except for 
group 4 at 30 min (p<0.02).  
Fig. 3. Left ventricular end-diastolic pressure 
(LVEDP) in isolated, perfused rat hearts. Group I 
(—): H2O2 (180 M) for 10 min followed by 
50 min recovery. Group II (—) and III (—) 
were given vehicle and H290/51, respectively, for 
10 min. Group IV (—) was perfused with H2O2 
like group I, as well as H290/51. In group V 
perfusion with H290/51 started when H2O2 
perfusion ended (—). *denotes p<0.025 
compared to H2O2-perfused hearts. Values are 
mean  SEM. 
 
 
Left ventricular developed pressure 
Administration of H290/51 and/or vehicle (groups II and III) alone had no significant effects 
on LVDP. H2O2 (group I) reduced LVDP to a minimum of 25±2 mmHg after 10 min. 
Between 5 and 20 min LVDP was significantly reduced as compared to the baseline value (p<
0.001). LVDP gradually recovered to 84±7 mmHg after 60 minutes. Neither addition of 
H290/51 during H2O2 perfusion and recovery (group IV), nor during recovery only (group V) 
significantly influenced the H2O2 -induced reduction in LVDP (Table 1).  
Coronary flow 
CF was 11±0, 10±1, 11±1, 11±1 and 12±1 ml/min at time 0 in groups I-V, respectively (Table 
1). H2O2 (group I) increased CF to 15±1 ml/min after 5 min (p<0.001), and it remained higher 
than the basal value (time 0) throughout the observation period. Addition of H290/51 or the 
vehicle to the perfusate (groups II and III) did not significantly influence CF. In group IV CF 
was similar to group I or even higher (20 min, p<0.02)(Table 1). In group V CF was not 
different from group I).  
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Heart rate 
There was a tendency of HR to increase during H2O2 perfusion in groups I, IV and V, but no 
significant intra- or intergroup differences were recorded during the observation period.  
 
 Group 0  min 5 min 10 min 15 min 20 min 30 min 60 min 
CF (ml/min) I 11 ± 0 15 ± 1** 14 ± 0** 14 ± 1* 14 ± 1* 15 ± 1* 13 ± 1* 
 II 10 ± 1 13 ± 1 13 ± 1 11 ± 1 11 ± 1 12 ± 1 12 ± 1 
 III 11 ± 1 13 ± 1 12 ± 1 13 ± 1 13 ± 1 13 ± 1 13 ± 1 
 IV 11 ± 1 15 ± 0** 14 ± 0* 14 ± 0* 16 ± 0** 17 ± 1** 13 ± 1 
 V 12 ± 1 15 ± 0** 13 ± 1 12 ± 1 13 ± 1 14 ± 1* 11 ± 0 
LVSP (mmHg) I 90 ± 6 55 ± 4** 42 ± 2** 60 ± 3** 82 ± 5* 95 ± 3 97 ± 4 
 II 88 ± 6 104 ± 6 109 ± 5 102 ± 11 103 ± 6 107 ± 5 102 ± 4 
 III 95 ± 8 107 ± 11 114 ± 12 110 ± 10 111 ± 10 111 ± 8 104 ± 8 
 IV 90 ± 4 62 ± 5** 45 ± 2** 62 ± 2** 73 ± 2** 93 ± 5 86 ± 4 
 V 91 ± 5 58 ± 3** 49 ± 2** 63 ± 3** 71 ± 2** 83 ± 4* 85 ± 6 
LVDP (mmHg) I 90 ± 6 48 ± 4** 25 ± 2** 35 ± 3** 50 ± 4** 77 ± 6 83 ± 6 
 II 88 ± 6 103 ± 6 108 ± 6 102 ± 11 103 ± 6 107 ± 5 103 ± 4 
 III 95 ± 8 107 ± 11 114 ± 11 110 ± 10 111 ± 9 111 ± 8 104 ± 8 
 IV 90 ± 4 56 ± 6** 30 ± 3** 46 ± 4** 64 ± 4* 90 ± 5 85 ± 4 
 V 90 ± 5 53 ± 3** 35 ± 2** 41 ± 5** 55 ± 3** 74 ± 5 80 ± 6 
Table 1. Hemodynamic measurements in Langendorff-perfused rat hearts perfused with H2O2 alone or 
with addition of the antioxidant H290/51. Values are mean  SEM of left ventricular systolic pressure 
(LVSP), coronary flow (CF), left ventricular developed pressure (LVDP). *, ** and *** denote 
p<0.05, p<0.01 and p<0.001, respectively, compared with initial value,  denotes p<0.05 compared to 
H2O2  alone. For details about groups, see methods.  
Biochemical data 
Release of lactate dehydrogenase 
At time 0 there was no significant difference between groups in LDH activity release. LDH 
release did not change during perfusion in groups II and III (Fig. 4). After 10 min perfusion 
with H2O2 (group I), LDH activity was similar to controls. However, LDH increased during 
recovery (maximum 64  29 U/min  10-3 at 30 min, p < 0.02 compared to baseline value). 
H290/51 (group IV) significantly inhibited the H2O2 –induced increase in LDH, but not when 
it was given after H2O2 perfusion (group V). 
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Fig. 4 Lactate dehydrogenase (LDH) activity 
released into the coronary effluent from V 
groups of isolated, perfused rat hearts. Group 
I (—) was given H2O2 (180 M) for 10 
min followed by 50 min recovery. Group II 
(—) and III (—) were given vehicle 
and H290/51, respectively, for 10 min. Group 
IV (—) was perfused with H2O2 like 
group I with the addition of H290/51 from 
time 0. In group V perfusion with H290/51 
started when H2O2 perfusion ended (—). 
* denotes p<0.05 compared to baseline value. 
Values are mean  SEM. 
Tissue content of TBARS 
The basal level of TBARS (time 0) was 0.6  0.04 nmol/g tissue. The level of TBARS in 
groups II and III did not change throughout the experiments. After perfusion with H2O2 for 10 
min TBARS increased to 3.1  0.4 nmol/g (p<0.001). Five minutes later TBARS had returned 
to baseline level. Addition of H290/51 (group IV) significantly inhibited the H2O2-induced 
increase in TBARS at 10 min (0.9  0.03 nmol/g, p < 0.001)(Fig. 5). 
Fig. 5 Tissue levels of thiobarbituric acid-reactive 
substances (TBARS) in 2 groups of isolated rat 
hearts. One group is perfused with H2O2 (180 M) 
from time 0 to 10 min, followed by recovery (—
). The other group (—) was given H290/51 
from time 0, in addition to H2O2 as described. 
Compared to baseline value TBARS were 
significantly elevated after 10 min in the group 
given H2O2 alone. * denotes that H290/51 inhibited 
the H2O2-induced increase in TBARS (p<0.001). 
Values are mean  SEM. 
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Isolated rat hearts subjected to ischemia-reperfusion – quantitative electron microscopical 
morphometry.  
Morphometry 
Absolute volume of ventricular myocardium and different tissue components 
There was no significant change in the volume of ventricular myocardium, myocytes, 
myofilaments, mitochondria or capillaries after 30 minutes of global ischemia in either group 
Table 2). However, the cytosolic volume was significantly increased in both groups after 
ischemia and returned to baseline after reperfusion. The extracellular interstitium increased in 
the control group compared to baseline at the end of ischemia. Treatment with H290/51 
inhibited this increase. At the end of reperfusion the interstitium of both groups had increased 
compared to baseline, but there was no difference between the two groups. In addition to the 
increases of the volume of the interstitium, both the ventricular volume and the volume of 
mitochondria had increased after reperfusion in control hearts, but not in the H290/51 treated 
group. This difference was not significant between groups (Table 2).  
    0 min  30 min  50 min 
      end of ischemia  end of reperfusion 
 Ventricular volume Group A  663  92  768  104  955    84* 
  Group B  775  87  782    94  922  146 
         
 Myocyte Group A  430  81  473    43  532    69 
  Group B  460  80  554    90  472  139 
         
 Myofil Group A  266  65  219    40  295    63 
  Group B  271  36  286    57  253    94 
         
 Mitochondria (total) Group A  142  22  179    27  204    30* 
  Group B  161  36  206    48  181    55 
         
 Cytosol Group A    19  10    68    33*    23    15 
  Group B    14    4    47    21*    24    15 
         
 Interstitium Group A  177  47   247    80*#  342  109* 
  Group B  232  31  159    50  389    64* 
         
 Capillaries Group A    62  20    47    20    80    38 
  Group B    82  35    68    17    61    24 
Table 2. Effects of 30 minutes of ischemia followed by 20 minutes of reperfusion on absolute volumes 
(l) of ventricular myocardium and different tissue components in isolated, perfused rat hearts 
(controls = group A and hearts treated with H290/51 = group B) (n=6 in each group at each time 
point). * Denotes p < 0.05 compared to baseline value. # Denotes p < 0.05 between groups. 
Megváltozott a mezőkód
(2016.07.03.NA PhD FINAL.doc) 26 
         
   0 min  30 min  50 min  
     end of ischemia  end of reperfusion  
         
Vv (myocyte/myocard)        
 Group A  0.645  0.060   0.622  0.071   0.562  0.090   
 Group B  0.591  0.036   0.707  0.052 * #  0.505  0.079 *  
           
Vv (interstitium/myocard)           
 Group A  0.355  0.060   0.318  0.062 #  0.356  0.105   
 Group B  0.305  0.064   0.206  0.067   0.431  0.093 *  
           
Vv (capillary/myocard)           
 Group A  0.091  0.022   0.059  0.019 *#  0.083  0.038   
 Group B  0.104  0.034   0.087  0.021   0.065  0.017   
         
Table 3. Effects of 30 minutes of ischemia followed by 20 minutes of reperfusion on the calculated 
volume fractions of different tissue components in isolated, perfused rat hearts (controls = group A 
and hearts treated with H290/51 = group B) (n=6 in each group at each time point). * denotes p < 0.05 
compared to baseline value. # denotes p < 0.05 between groups. 
 
         
   0 min  30 min  50 min  
     end of ischemia  end of reperfusion  
         
Vv (mito/myocyte)        
 Group A  0.333  0.023   0.380  0.052 *  0.386  0.049 *  
 Group B  0.347  0.021   0.367  0.040   0.387  0.064   
           
Vv (alt mito/myocyte)           
 Group A         0  0   0.307  0.094 *  0.158  0.187 *  
 Group B         0  0   0.233  0.145 *  0.200  0.139 *  
           
Vv (cell edema/myocyte)           
 Group A  0.047  0.025   0.144  0.070 *#  0.044  0.030   
 Group B  0.031  0.012   0.083  0.033 *  0.054  0.039   
         
Table 4.  
Effects of 30 minutes of ischemia followed by 20 minutes of reperfusion on the calculated volume 
fractions of different subcellular organelles in myocytes in isolated, perfused rat hearts (controls = 
group A and hearts treated with H290/51 = group B) (n=6 in each group at each time point). * Denotes 
p < 0.05 compared to baseline value. # Denotes p < 0.05 between groups. 
Volume fractions of different tissue components in the myocardium  
Relative volumes of tissue components calculated as volume fractions (Vv) of the 
myocardium are presented in (Table 3). The volume fraction of myocytes increased after 
ischemia in the treated group, and at this time point it was also higher than in the control 
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group. During reperfusion it decreased in both groups without any difference between groups. 
Ischemia increased the volume fraction of the interstitium in control hearts compared to 
baseline. This increase was inhibited in the group given H290/51, but during reperfusion the 
volume fraction of the interstitium increased in the treated group. The decreased volume 
fraction of capillaries in the myocardium after ischemia was inhibited by H290/51(Table 3).  
Volume fractions of subcellular components versus myocytes 
Volume fractions of mitochondria increased in control hearts at the end of ischemia and 
remained high during reperfusion (Table 5). This increase was prevented by H290/51, but 
there was no difference between groups. Alterations of mitochondria were observed at the end 
of ischemia and during reperfusion in both groups without any effect of H290/51. Ischemia 
increased the relative volume of cytosol within the cardiomyocytes (Vv cell edema/myocyte) 
in both groups, and this increase was significantly higher in hearts not pretreated with 
H290/51 (Table 5). During reperfusion the volume fraction of cytosol normalized in both 
groups. 
         
   0 min  30 min  50 min  
     end of ischemia  end of reperfusion  
         
Vv (mito/myocyte)        
 Group A  0.333  0.023   0.380  0.052 *  0.386  0.049 *  
 Group B  0.347  0.021   0.367  0.040   0.387  0.064   
           
Vv (alt mito/myocyte)           
 Group A         0  0   0.307  0.094 *  0.158  0.187 *  
 Group B         0  0   0.233  0.145 *  0.200  0.139 *  
           
Vv (cell edema/myocyte)           
 Group A  0.047  0.025   0.144  0.070 *#  0.044  0.030   
 Group B  0.031  0.012   0.083  0.033 *  0.054  0.039   
         
Table 5. Effects of 30 minutes of ischemia followed by 20 minutes of reperfusion on the calculated 
volume fractions of different subcellular organelles in myocytes in isolated, perfused rat hearts 
(controls = group A and hearts treated with H290/51 = group B) (n=6 in each group at each time 
point). * denotes p < 0.05 compared to baseline value. # denotes p < 0.05 between groups. 
Ultrastructural changes in the myocardium 
Before ischemia myocytes with mitochondria and other cell organelles appeared normal as 
did the endothelial cells. There was no difference in control hearts perfused with H290/51 
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(Group C) at the end of perfusion compared to preischemic micrographs. The results of Group 
C are not further commented upon. 
Fig. 6. Two myocytes are shown on the 
micrograph sampled from control group 
(Group A) after 30 min ischemia. One of them 
reveals a moderate intracellular edema with 
moderate mitochondrial swelling and intact 
sarcolemma. The other is damaged, 
edematous, the myofilamental pattern (MF) is 
disrupted. The cytoplasm of the endothelial 
cell is edematously swollen with luminal 
protrusions (arrow). Chromatin margination of 
the nucleus (N) is observed. The inserted 
micrograph shows a fairly well maintained 
structure, apart from fragmentation of the 
sarcolemma. ×10000.  
 
 
 
After ischemia areas with damaged cells were observed on most micrographs. In control 
hearts (Group A) myocytes were swollen with perimitochondrial and perimyofibrillar edema 
(Fig. 6). In severely damaged myocytes the sarcolemma was fragmented. Subsarcolemmal 
blebs occurred in more severely injured myocytes with massive cell swelling. The 
myofilamental pattern became irregular and Z lines were distorted. In more severely injured 
myocytes myofilaments were disrupted with a loss of Z lines. Mitochondria generally 
appeared swollen and rounded. The mitochondrial matrix showed a loss of electron density. 
Occasionally, mitochondrial cristae were broken or amorphous matrix densities appeared 
showing severe damage. Cristal adhesions were found in severely altered mitochondria. There 
was also evidence of tissue edema and endothelial cells showed swelling with luminal 
protrusions. Cellular debris accumulated where severe damage was evident. Thirty minutes of 
ischemia also caused margination of nuclear chromatin in both endothelial and myocardial 
cells. On micrographs sampled from hearts treated with H290/51 (Group B) the ischemic 
damage was less apparent, the structure remained fairly normal (Fig. 7.). In most myocytes 
törölt: <objektum>
Megváltozott a mezőkód
Megváltozott a mezőkód
(2016.07.03.NA PhD FINAL.doc) 29 
myofilamental pattern was better preserved and edematous changes were less marked both 
intracellularily and interstitially. However, foci of damaged myocytes were observed. 
 
Fig. 7. Electron micrograph taken 
of rat heart treated with H290/51 
exposed to 30 min ischemia. The 
structure is fairly well maintained, 
apart from a mild intracellular 
edema. The capillary wall (CW) 
reveals a normal structure, the 
chromatin is finely dispersed in 
the nucleus of the endothelial cell. 
On the insert the myocardium is 
damaged. The mitochondrial 
cristae are disrupted (arrow). The 
remnants of myofilaments are 
only partly preserved. The nuclear 
chromatin margination is 
conspicuous (N). ×10000.  
 
 
Most ischemic changes persisted after reperfusion. There were no signs of progressive 
damage during reperfusion. Interstitial edema tended to increase in the control group. Within 
the myocytes the fluid accumulation seen after ischemia decreased during reperfusion. 
Myofilamental pattern was restored on many micrographs. 
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Isolated rat hearts subjected to ischemia-reperfusion – biochemical and functional analysis 
Functional measurements 
Heart rate and severe arrhythmias 
No significant intra- or intergroup differences were recorded during the observation period. 
Severe arrhythmias occurred early in reperfusion in all groups. Significantly less severe 
arrhythmia occurred in hearts treated with H290/51 throughout perfusion (group 4) compared 
to controls (p<0.0001). (Fig. 8). 
Fig. 8. Proportion of hearts with severe arrhythmias 
in isolated, Langendorff perfused rat hearts 
subjected to 30 min global ischemia followed by 60 
min reperfusion. Group 1: Ischemic controls 
(-). Group 2: Vehicle added throughout 
perfusion ( - ). Group 3: Vehicle added before 
ischemia, and H290/51 added during reperfusion 
( - ). Group 4: H290/51 added throughout the 
experiments (-). * denotes p<0.0001 compared 
to controls.  
 
 
Left ventricular developed pressure 
LVDP was 995, 945, 904 and 91 4 mmHg at time 0 in groups 1-4, respectively. LVDP 
decreased significantly during reperfusion to 623 mmHg at 90 minutes in ischemic controls 
(p<0.004, at 70 min and 90 min, group 1). LVDP was significantly higher at 70 and 90 
minutes (p<0.008 and p<0.003, respectively) in hearts given H290/51 throughout perfusion 
(group 4) (Fig. 9). H290/51 given only during reperfusion had no significant effect on LVDP. 
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Fig. 9. Left ventricular developed pressure in 
isolated, Langendorff perfused rat hearts 
subjected to 30 min global ischemia followed by 
60 min reperfusion. Group 1: Ischemic controls 
(-). Group 2: Vehicle added throughout 
perfusion ( - ). Group 3: Vehicle added 
before ischemia, and H290/51 added during 
reperfusion ( - ). Group 4: H290/51 added 
throughout the experiments (-). n=10 in all 
groups, values are mean ± SEM. ‡ denotes 
p<0.05 compared to initial value, * denotes 
p<0.05 compared to controls. 
 
Left ventricular end-diastolic pressure 
LVEDP was 0 mmHg at time 0 in all groups. LVEDP increased during reperfusion in group 1 
to a maximum of 31  12 mmHg after 5 min reperfusion (35 minutes of observation) 
(p<0.001), and remained high throughout the experiment. H290/51 (group 4) attenuated the 
increase of LVEDP after 32 and 35 minutes of observation (p<0.001 and p<0.008 
respectively) (Fig. 10). 
 
Fig. 10. Coronary flow in isolated, Langendorff 
perfused rat hearts subjected to 30 min global 
ischemia followed by 60 min reperfusion. Group 1: 
Ischemic controls (-). Group 2: Vehicle added 
throughout perfusion ( - ). Group 3: Vehicle 
added before ischemia, and H290/51 added during 
reperfusion ( - ). Group 4: H290/51 added 
throughout the experiments (-). n=10 in all 
groups, values are mean ± SEM. * denotes p<0.05 
compared to controls. 
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Coronary flow 
CF was 111, 130, 121 and 131 ml/min at time 0 in groups 1-4, respectively. CF 
gradually decreased to 6.1 0 ml/min after 90 min observation in ischemic controls (p<0.0001 
from 45 minutes onwards). Addition of H290/51 (group 4) significantly attenuated the 
ischemia-induced decrease in CF from 45 minutes onwards (p<0.006 at all time points)(Fig. 
11). Delayed administration of H290/51 (group 3) or adding vehicle only (group 2) also 
attenuated, although less pronounced, the ischemia-induced decrease in CF (p<0.01 at 50, 60 
and 70 minutes) (Fig. 5). 
Fig. 11. Coronary flow in isolated, Langendorff 
perfused rat hearts subjected to 30 min global 
ischemia followed by 60 min reperfusion. Group 1: 
Ischemic controls (-). Group 2: Vehicle added 
throughout perfusion ( - ). Group 3: Vehicle 
added before ischemia, and H290/51 added during 
reperfusion ( - ). Group 4: H290/51 added 
throughout the experiments (-). n=10 in all 
groups, values are mean ± SEM. ‡ denotes p<0.05 
compared to initial value, * denotes p<0.05 
compared to controls. 
 
 
Biochemical data 
Release of LDH 
LDH activity in the effluent was 20.22.2, 19.32.2, 18.42.1 and 20.53.2 U/min* 10-3 at 
time 0 in groups 1-4, respectively. LDH increased during reperfusion in ischemic controls 
(group 1) (maximum 94.536.0 U/min* 10-3 at after 5 minutes of reperfusion, p<0.002)(Fig. 
12). Vehicle only did not influence LDH release (maximum 79.1 13.0 U/min* 10-
3
 at 5 min 
reperfusion, p<0.001)(Fig. 12). H290/51 throughout perfusion (group 4) inhibited the 
ischemia-induced LDH release, and was significantly different from controls after reperfusion 
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for 5 minutes (p<0.002). Delayed administration of H290/51 (group 3) resulted in higher 
LDH release than group 4, but lower than groups 1 and 2. 
Fig. 12. Lactate dehydrogenase activity in the 
coronary effluent of isolated, Langendorff-
perfused rat hearts subjected to 30 min global 
ischemia followed by 60 min reperfusion. Group 
1: Ischemic controls (-). Group 2: Vehicle 
added throughout perfusion ( - ). Group 3: 
Vehicle added before ischemia, and H290/51 
added during reperfusion ( - ). Group 4: 
H290/51 added throughout the experiments 
(-). n=10 in all groups, values are mean ± 
SEM. ‡ denotes p<0.05 compared to initial value, 
* denotes p<0.05 compared to controls. 
 
Tissue content of TBARS 
The group given vehicle only had the highest tissue content of TBARS at baseline (n.s.). 
There was no increase in TBARS after ischemia in group 1 compared to baseline. However, 
H290/51 reduced TBARS during reperfusion as compared to group 1 (at 40 and 60 min, 
p<0.004 and 0.001, group 4). 
Fig. 13. Thiobarbituric acid-reactive subastances 
(TBARS) content in freeze-clamped isolated, 
Langendorff perfused rat hearts subjected to 30 min 
global ischemia followed by 60 min reperfusion. 
Group 1: Ischemic controls (-). Group 2: Vehicle 
added throughout perfusion ( - ). Group 3: Vehicle 
added before ischemia, and H290/51 added during 
reperfusion ( - ). Group 4: H290/51 added 
throughout the experiments (-). n=10 in all 
groups, values are mean ± SEM. * denotes p<0.05 
compared to controls. 
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DISCUSSION  
Does reperfusion injury exist? 
The importance of reperfusion injury is often debated and somewhat controversial. There are 
numerous findings consistent with the occurrence of necrosis during reperfusion (Röth et al., 
1987; Matsumura et al., 1998; Becker et al., 1999; Bolli, 1998). Some investigators, however, 
could not demonstrate the extension of necrosis on reperfusion by electron microscopy (Ganz 
et al., 1990) and attributed cell death predominantly to ischemia and not to reperfusion (Klein 
et al., 1996). Hence, it is not settled whether reversibly injured myocytes, potentially viable at 
the time of reperfusion, die as a consequence of reperfusion (Ferrari, 1997). There are 
arguments that the major part of myocardial injury occurs during ischemia, even if 
manifesting itself both histologically and functionally only after reperfusion (Robicsek and 
Schaper, 1997). The apparent controversy can, however, be resolved in part by making a 
distinction between reversible and irreversible reperfusion injury. There is a bulk of evidence 
supporting reversible reperfusion injury. On the other hand, the existence of lethal reperfusion 
injury remains highly controversial since there are not enough conclusive data available from 
reproducible, controlled experiments. Most investigators seem to agree, however, that 
reperfusion injury is a true entity and that there are sufficient theoretical reasons suggesting 
the existence of lethal reperfusion injury (Ferrari, 1998). 
Updated view on ROS  
It has recently become evident that ROS are more than simply cellular toxicants and that they 
may be important modulators of cellular gene expression patterns and also act as signal 
transduction molecules. Cellular H2O2 was transiently increased upon activation of platelet-
derived growth factor (Sundaresan et al., 1995). ROS can activate different cellular signalling 
molecules and pathways, such as Ca2+ and protein tyrosine kinases. When cells are activated 
by extracellular stimuli, the cells produce ROS, which in turn stimulate other cellular 
signalling pathways, indicating that ROS act as second messengers (Kamata and Hirata, 
1999). There is also a role of ROS in the induction of apoptosis. ROS can induce activation of 
caspases, which in turn cause cell death (Ceselli et al., 2001). 
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Methodological considerations 
Pharmacological interventions and surgical procedures for the treatment of myocardial 
ischemia followed by reperfusion must rely on proper knowledge of the underlying 
pathophysiological mechanisms. The recommended therapy should be based on appropriately 
designed and conducted clinical trials. Nevertheless, much basic pathophysiological insight 
originates from animal experiments. Hence, animal models will continue to be of fundamental 
importance for the development of new treatment modalities. A major factor in an 
experimental model is the animal species used. Rats, dogs and pigs are most frequently used. 
Dogs are increasingly more difficult to obtain because of ethical concerns and high costs. The 
other disadvantage of dogs is the difference in coronary structure, that is, in contrast to 
humans, dogs have a substantial collateral circulation. In our experiments we used rats, which 
are very suitable if a large number of animals are required, mainly for ex vivo preparations. 
The availability of genetically homogeneous strains ensures reproducibility. These animals 
are easy to handle and inexpensive. The use of pigs is more relevant when a large animal is 
needed or when in vivo experimental conditions are needed. 
Isolated hearts 
In studies II through IV we employed the Langendorff model. It is a stable, easy to control 
preparation, and technically simple thus enabling several sets of experiments to be performed. 
A major advantage of the isolated heart model is that global ischemia results in a homogenous 
tissue response that enables the use of homogenized tissue for biochemical analyses. It should 
be noted, however, that the perfusion solution is lacking blood cells, plasma proteins, growth 
factors and this per se can lead to changes in heart function independent of ischemia-induced 
damages. The organ is also denervated and without hormonal stimuli. However, the isolated 
rat heart is a suitable model for screening drugs. Due to its advantages this model has become 
a first-choice model for studies of the biochemical and cellular consequences of myocardial 
ischemia-reperfusion. An intraventricular balloon was inserted for pressure readings in studies 
II and IV. This, however, may cause perfusion defects in the papillary muscle and eventually 
necrosis and therefore hemodynamic measurements were not employed in the experiment 
aimed at ultrastructural analysis (Study III). 
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Exogenous H2O2 as a model of oxidative injury 
H2O2 was chosen as a convenient and reproducible model of generating injury by exogenous 
free radicals. H2O2 is inexpensive, easy to store and add to the perfusate. Increased 
postischemic tissue levels of H2O2 have been measured in isolated rat (Brown et al., 1989), 
and rabbit hearts (Shlafer et al., 1990). The levels of H2O2 correlated to depression of cardiac 
performance. Addition of exogenous H2O2 to mammalian cardiomyocytes in vitro produced a 
lethal peroxidative membrane injury (Janero et al., 1991). Infusion of H2O2 into rabbits caused 
a rapid irreversible deterioration of cardiac function (Ambrosio et al, 1992.). The exact 
mechanism of H2O2-induced injury is not completely elucidated. H2O2 may have direct 
cardiodepressive effects (Valen, 1993; Takemura, 1993). H2O2 is also the source of the highly 
toxic hydroxyl radical in the Haber-Weiss reaction catalyzed by intracellular or membrane 
bound transition metals, which initiates lipid peroxidation (Cochrane, 1991). The feasibility of 
perfusing isolated rat hearts with hydrogen peroxide to study the effects caused by reactive 
oxygen species has been tested in our laboratory (Skjelbakken, 1996). In that study H2O2 
rather than the hydroxyl radical was found to be the main injurious ROS in this model. In our 
experiments a 10 min perfusion with H2O2 was employed to obtain a reversible, non-lethal 
model with marked cardiodepression. The length of administration of H2O2 and its 
concentration was selected on previous experiments in our laboratory where these parameters 
were necessary to achieve the required cardiac dysfunction (Valen, 1993). 
TBARS 
In Studies II and IV we employed TBARS as a nonspecific marker of abnormal tissue 
oxidation. Although TBARS did not increase during reperfusion, the tissue contents were 
lower during reperfusion in hearts perfused with H290/51. However, in isolated rat hearts 
injured by hydrogen peroxide for 10 minutes (Study II), significant functional and 
biochemical injury occurred concomitant with increased levels of TBARS in the heart. 
Adding H290/51 to the perfusate attenuated both functional and biochemical injury, and 
inhibited accumulation of TBARS (Study II). 
 
TBARS are usually regarded as being representative of MDA, despite of well-known 
limitations as a measure of lipid peroxidation (Esterbauer et al, 1991). Additionally, 
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production of TBARS may not necessarily correlate with functional impairment after 
reoxygenation (Salaris and Babbs, 1988). Studies on possible accumulation of lipid 
peroxidation products in heart tissue and effluent from ischemic-reperfused hearts have 
yielded highly conflicting results. Generation of ROS without concomitant detection of MDA 
has been found in cardiac tissue. In a model of 10 minutes of normothermic ischemia to 
isolated rat hearts, ROS were measured directly with electron paramagnetic resonance 
spectroscopy, but no evidence of lipid peroxidation was found (Monpoil and Rochette, 1988). 
In another work, isolated rat hearts were exposed to exogenous free radicals in the perfusate, 
or subjected to ischemia for 60 minutes (Ballagi-Pordany, 1991). Only the group with the 
most severe radical-induced injury had increased tissue levels of MDA. MDA is an end 
product of lipid peroxidation, and not all free radical induced injury may lead to accumulation 
of end products of lipid peroxidation. No release of MDA was observed from the 
cardioplegic-reperfused human heart (Valen et al, 1994). It may be that the antioxidant 
defense was able to quench the peroxidation chain reaction before reaching the end product. 
Thus, only an extreme oxidant stress may be able to significantly increase the end products of 
lipid peroxidation. 
H290/51 
In the present experiments we studied the effect of H290/51, an indenoindole type compound, 
on ischemia-reperfusion injury in different experimental settings. Indenoindole compounds 
have previously been shown to inhibit lipid peroxidation in several test systems (Shertzer and 
Sainsbury, 1991; Shertzer and Sainsbury, 1988; Westerlund et al, 1996). As H290/51 is a 
small molecule with water-soluble and lipophilic properties, it will easily and rapidly get 
access to the intracellular sites of ROS generation, lipid peroxidation, and oxidant injury. 
These properties make H290/51 an interesting compound with clinical potential.  
 
H290/51 was originally regarded as an inhibitor of lipid peroxidation only. However, it has 
other actions as well not related to its antioxidant properties. It inhibits upregulation of nNOS 
during heat stress (Alm et al. 2000) , and in the same model attenuates upregulation of 72 kD 
heat shock protein (Hedlund et al., 1999). These observations may indicate properties of 
H290/51 beyond inhibition of lipid peroxidaton. Vitamin E also has properties other than as 
an antioxidant only. It may inhibit atherogenesis through several other mechanisms at the 
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molecular and cellular levels (Meydani, 2001). Vitamin E can inhibit smooth muscle cell 
proliferation and growth during atherosclerosis through inhibition of protein kinase C activity 
(Boscoboinik et al., 1994). Vitamin E was shown to inhibit production of chemokines by the 
endothelium. The modulation of adhesion molecules appears to be through inhibition of ROS-
sensitive signalling pathways (Wu et al., 1999).  
Discussion of results 
Myocytes subjected to hypoxia/reoxygenation 
Reoxygenation of isolated myocytes after 1 hour of hypoxia resulted in a time-related injury 
evidenced by LDH leakage. H290/51 almost completely prevented this injury at a 
concentration of 10-6 mol/l. This concentration was therefore selected in further experiments 
with isolated rat hearts. Our findings were similar to that of the effect of Vitamin E reported 
in corresponding experimental conditions (Ek et al., 1994). 
H2O2 perfusion 
Exposure to exogenous H2O2 impaired left ventricular function evident as a marked elevation 
of LVEDP and a decrease in LVDP (Study II). Similar functional deterioration occurs in post-
ischemic myocardial stunning (Bolli, 1998). The observed left ventricular dysfunction was 
partly reversible, the diastolic dysfunction being more long-lasting. H2O2 induced a sustained 
increase in CF. Concomitant with the functional changes LDH release occurred, indicating 
myocyte damage. The observed effects of H2O2 are in agreement with previous studies (Valen 
et al., 1993; Lesnefsky, 1991). The increase of TBARS in the hearts after perfusion with H2O2 
confirmed that oxidative stress and lipid peroxidation occurred. Administration of H290/51 
attenuated the cardiac injury induced by exogenous ROS. H290/51 inhibited the rise in 
LVEDP caused by H2O2 and LVEDP normalized by the end of the experiments in contrast to 
the group given only H2O2 where LVEDP was increased throughout the observation period. 
As the decrease in LVSP and LVDP was not influenced it appears that H290/51 attenuated 
ROS-induced diastolic, but not systolic dysfunction. In addition H290/51 inhibited LDH 
release after H2O2 exposure. Consequently H290/51 reduced both biochemical and functional 
injury induced by H2O2. Inhibition of H2O2-induced increase in TBARS demonstrates that 
H290/51 did inhibit lipid peroxidation in the present model of cardiac injury by exogenous 
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ROS. The delayed administration of H290/51 following H2O2 also resulted in a reduction, 
albeit less pronounced, of oxidant injury. This suggests that lipid peroxidation occurred even 
after the end of H2O2 administration.  
Ultrastructural alterations after global ischemia 
Ischemia and reperfusion caused interstitial and cellular edema, disruption of sarcolemma, 
swollen mitochondria and myofilament disruption. These findings are in agreement with 
earlier studies (Hearse, 1998; Jennings and Ganote1994; Schaper, 1986). Quantitative 
stereological morphometry suggested that the hearts treated with H290/51 had less injury than 
control hearts. After ischemia the increased interstitial volume and the increased volume 
fractions of both interstitium and myocytes were inhibited by H290/51. This demonstrates 
that both extra- and intracellular edema after ischemia was inhibited or reduced by this drug. 
In addition the volume fraction capillary/myocardium was less in the control group at the end 
of ischemia. A relatively greater interstitial volume due to edema in the control group may 
explain this. In explaining volume fraction differences it should be noted, however, that 
volume fractions are given as ratios. An altered volume fraction may be due to an altered 
numerator or an altered reference volume.  
 
Surprisingly the differences between groups occurred at the end of ischemia, but no difference 
was found during reperfusion, although several changes compared to baseline were observed. 
One can speculate if some differences during reperfusion would have become apparent if the 
number of hearts had been increased or if the time point(s) for evaluation had been different. 
On the basis of our data we can only state that in the present study no tendency towards any 
difference between groups is evident in the reperfusion period. Consequently, from a 
morphological and ultrastructural point of view H290/51 has anti-ischemic rather than anti-
reperfusion effects.  
 
Another explanation of why the antioxidant was effective during ischemia is the fact that 
production of ROS takes place already during ischemia. This phenomenon was measured by 
electron paramagnetic resonance spectroscopy (Zweier, 1987) and recently with a fluorescent 
probe method (Becker et al., 1999). If there is a progressive ROS generation during ischemia, 
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it is evident why lipid peroxidation inhibitor H290/51 was more effective when given already 
during ischemia and not only from the start of reperfusion in Study IV. Possibly in Study III 
the present concentration of H290/51 was able to quench the ROS during ischemia, but was 
not capable to counteract the burst during reperfusion. This concentration was, however, 
protective against reoxygenation injury in cultured myocytes (Study I). The same 
concentration in Study IV resulted in attenuation of ischemia-reperfusion injury measured 
both functionally and biochemically.  
 
In the present study the morphological alterations were surprisingly few, except for an 
increase of mitochondrial, interstitial, and the left ventricular volume indicating intra- and 
extracellular edema, with the ultrastructure becoming more normal during reperfusion. The 
increasing edema may be the continuation of an ischemic injury and does per se suggest that 
reperfusion did take place.  
 
Ultrastructural changes of the mitochondria are a crucial step in the development of ROS-
induced myocardial damage (Hegstad et al., 1994; Lucas and Szweda, 1998). H290/51 did not 
influence the appearance of mitochondria after ischemia. Vv(alt mito/myocard) remained 
similar in both groups at the end of 20 minutes of reperfusion. The absolute volume of 
mitochondria, however, was increased only in the group without H290/51, but only during 
reperfusion. The increase of Vv mito/myocyte observed in the untreated group both after 
ischemia and reperfusion indicated that mitochondria were swollen above the extent of the 
general myocardial swelling in this group. Others (Ytrehus, 1987) have reported results 
similar to our findings. In these experiments supplementation of superoxide dismutase and 
catalase to isolated rat hearts subjected to ischemia - reperfusion resulted in a better preserved 
sarcolemmal integrity. However, no differences were detected in mitochondrial swelling. A 
parallel effect was observed after reperfusion of dog skeletal muscle rendered ischemic 
(Ytrehus et al., 1995). It is possible that in our experiments the protection afforded by 
H290/51 was similar, i.e. a protection on cellular membranes and sarcolemmal integrity, but 
less on mitochondria.  
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Functional changes following global ischemia 
Thirty minutes of global, normothermic ischemia impaired left ventricular function evident as 
a marked increase of LVEDP, and a decrease of LVDP and CF during reperfusion. 
Concurrently LDH release increased, indicating myocyte damage. The decrease in CF was 
more marked following ischemia/reperfusion in the control group indicating development of a 
no-reflow phenomenon. The exact mechanism of no-reflow implies many pathways, and only 
a part of these has been clarified. A major role of ROS is assumed through the induction of 
microvascular damage. The vascular injury may be manifest as microvascular spasm, 
extravascular compression due to interstitial edema, and endothelial swelling (Eeckhout et al., 
2001). H290/51 given throughout perfusion inhibited both the biochemical and functional 
injury induced by ischemia-reperfusion. This is in accordance with a study performed in the 
working rat heart model, where the effect of H290/51 on ischemia-reperfusion injury after 
cold cardioplegic arrest was investigated (Wang et al., 1995). In this study, however, H290/51 
was given only together with cardioplegia infusion at the onset of ischemia. The difference in 
our study was that with preischemic administration, H290/51 provided a more marked 
functional and biochemical protection compared to its effect when it was given only during 
reperfusion. Oxidant injury with production of ROS probably takes place predominantly in 
the first 30-60 seconds of reperfusion (Bolli, 1992). Ideally H290/51 should be at the site of 
ROS production before reperfusion starts for maximal effect, and this may explain that 
H290/51 during reperfusion only had less protective effect. However, we cannot exclude a 
possible direct anti-ischemic effect of H290/51 in addition to anti-reperfusion effects. 
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CONCLUSIONS 
The effects of an inhibitor of lipid peroxidation on different settings of ischemia-reperfusion 
injury were tested. The antioxidant selected for the experiments H290/51, is an indenoindole 
derivative. H290/51 was able to inhibit LDH leakage from cultured myocytes subjected to 
hypoxia/reoxygenation indicating a protective effect against oxidative injury. This effect was 
dose-dependent. Oxidative injury was generated by exogenous H2O2 perfusion in an isolated 
rat heart model resulting in a largely reversible functional and biochemical impairment of 
cardiac function (Study II). H290/51 attenuated diastolic dysfunction as it inhibited the 
increase in LVEDP casued by H2O2. The protective effect of this antioxidant was further 
evidenced by the inhibition of LDH release and accumulation of TBARS after H2O2 exposure. 
 
The effect of H290/51 on ischemia/reperfusion injury was studied in two experiments. 
Morphological alterations after global normothermic ischemia in the ultrastructure were 
evaluated by quantitative stereological morphometry and by qualitative histological 
examination in the isolated rat heart. H290/51 administration resulted in a better preserved 
sarcolemmal integrity and cellular volume control. The morphological difference was already 
present during ischemia but vanished during reperfusion. The protective effects of H290/51 
on myocardial ultrastructure during ischemia could form the basis for the better hemodynamic 
function of treated hearts in the reperfusion period in Study IV. 
 
Inhibition of lipid peroxidation after global normothermic ischemia resulted in a higher LVDP 
and less increased LVEDP (Study IV). The compound also inhibited malignant arrhythmias, 
attenuated the ischemia-induced decrease of CF. Biochemically, H290/51 inhibited the 
increased LDH release. Its effect was less evident when it was administered only from the 
start of reperfusion. 
 
Extrapolation of our in vitro findings to in vivo or clinical practice requires caution. But in 
vivo applicability of this compound was recently demonstrated by Shimizu et al (Shimizu et 
al., 1998) in pigs. H290/51 reduced infarct size induced by occlusion of left anterior 
descending artery and improved left ventricular functional recovery, supporting our 
conclusions from in vitro and ex vivo experiments. 
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Our data suggest that to some extent the antioxidant properties can be effective not only 
during reperfusion, but already during ischemia. A better preserved functional and 
morphological status of the myocardium during ischemia may yield a better capacity to 
survive reperfusion injury. The ability to rapidly reach the intracellular sites where 
ischemia/reperfusion injury and ROS generation takes place, makes H290/51 an interesting 
substance for clinical testing.  
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